Sort   by:  
 Page size 
UnknownImmunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients' knowledge to manage adverse effects.
Not available
S-EPMC7717911 | biostudies-literature
UnknownNeutropenic events associated with new anticancer treatments, from pathophysiology to practice: a scoping review-NEW Group (Neutropenic Events Working Group).
Not available
S-EPMC12672706 | biostudies-literature
UnknownTRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas.
Not available
S-EPMC12466217 | biostudies-literature
UnknownMetagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient Management.
Not available
S-EPMC6266913 | biostudies-literature
UnknownEvaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital.
Not available
S-EPMC11684108 | biostudies-literature
UnknownSynthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials.
Not available
S-EPMC12583804 | biostudies-literature
UnknownMetagenomic Investigation of Torque Teno Mini Virus-SH in Hematological Patients.
Not available
S-EPMC6759482 | biostudies-literature
UnknownThe CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
Not available
S-EPMC10659121 | biostudies-literature
UnknownThe CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.
Not available
S-EPMC10391746 | biostudies-literature
UnknownClinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified.
Not available
S-EPMC8405194 | biostudies-literature
Sort   by:  
 Page size